Generic drug firm sees global Q2 revenue rise 19%

Teva, the world’s leading generic pharmaceuticals company which employs almost 500 people in Ireland, has reported a 19% increase in global second-quarter revenues over the same period last year.

Global net revenue from Teva’s generics and branded medicines was $5bn (€3.9bn), up from $4.2bn (€3.4bn) in Q2 2011.

Teva Pharmaceuticals Ireland general manager Sandra Gannon said Teva is on a growth path as generic drugs become more widespread.